Form 4: Phathom Pharmaceuticals Executive Reports Stock Transaction
Insider Transaction (Form 4)
Robert Charles Breedlove, Principal Accounting Officer of Phathom Pharmaceuticals, Inc., reported a transaction in 1,555 shares of common stock on July 14, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,555 Common Stock at $11.04 ($17,159) on July 14, 2026; holds 59,925 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert Charles Breedlove — Officer (Principal Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Tax/exercise-price withholding | Common Stock | 1,555 | $11 | $17.2K | 59,925 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Tax/exercise-price withholding (1,555 shares) |
Keywords
insider transaction, Form 4, PHAT, Phathom Pharmaceuticals, Inc., neutral, Robert Charles Breedlove
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.